Cristiano Ferlini

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Martin Hutchings, Franck Morschhauser, Gloria Iacoboni et al. · Journal of Clinical Oncology · 2021 · 413 citations · Full text

Life Sciences, Immunology, Oncology +17

Role of microRNAs in drug-resistant ovarian cancer cells

Antonio Sorrentino, Chang‐Gong Liu, Antonio Addario et al. · Gynecologic Oncology · 2008 · 359 citations

Medicine, Molecular Biology, Oncology +12

Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.

Simona Mozzetti, Cristiano Ferlini, Paola Concolino et al. · PubMed · 2005 · 327 citations

Medicine, Oncology, Pharmacology +16

Class III β-Tubulin Overexpression Is a Prominent Mechanism of Paclitaxel Resistance in Ovarian Cancer Patients

Simona Mozzetti, Cristiano Ferlini, Paola Concolino et al. · Clinical Cancer Research · 2005 · 297 citations · Full text

Medicine, Oncology, Pharmacology +16

Defining “mutation” and “polymorphism” in the era of personal genomics

Roshan Karki, Deep Pandya, Robert C. Elston et al. · BMC Medical Genomics · 2015 · 265 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16